Reactions are coming in reacting to the sudden death of surgeon, researcher, and tireless patient advocate, Dr. Robert Bendavid, MD.
Writer, mesh-injured activist, and author, Nancy Gretzinger contributes this story about her experience with her implant and a controversial treatment.
Mesh News Desk is trying to clear up some of the confusion concerning the 2019 FDA decision about POP mesh, essentially removing it from the market. This applies to pelvic organ prolapse mesh only!
Even though the Food and Drug Administration began taking in mesh-related complaints in early 2000, nine years later the agency decided mesh to treat prolapse is not safe or effective and banned it.
Dr. Greg Vigna, MD, JD report that Boston Scientific is seeking the FDA approval of its mesh using the 522 orders which are an FDA-ordered review of complications.
Expert Panels often decide to approve drugs and devices, but how objective are the panelists when they have financial arrangements with those they are regulating?
Mesh News Desk, July 25, 2018 ~ This story originally ran in March of 2016 but after a conversation today with someone familiar with medical devices…
Pelvic Organ Prolapse (POP) polypropylene mesh, which has injured so many, has finally been reclassified as "High Risk" after giving industry another 30 months until moving it from moderate risk.
The Food and Drug Administration's 510(k) clearance process for medical devices has been called a fast-track clearance for medical devices bypassing assurances of safety and efficacy.
When Money Mixes with Medicine, Industry Influences get a Foothold with the FDA due to financial influences.
Family Tree of Meshes, Littman, shows the origins of pelvic mesh.
Pelvic meshes found detective in a court of law remain on the market and are regularly used, specifically polypropylene mesh used to treat incontinence in women.
Questions have been raised by readers - Is my doctor receiving funds from the industry that makes the mesh or medical devices he or she is using?
A Biomedical expert has been brought in as a consultant in some pelvic mesh cases. He shares that devices taken off the market soon find a way back on at the hands of industry.
Months after the U.S. Food and Drug Administration (FDA) warned a medical device could spread deadly uterine cancers, many hospitals and doctors are still using them.
Two days before an advisory panel was gathered to look at the controversial medical device called a morcellator, a gynecologist stepped down due to conflict of interest.
Fantastic researcher and friend, Suzanne McClain has always been the most competent person in digging through the U.S. Food and Drug data on the origins of mesh.
Some of the names in this story may sound familiar, primary among them Dr. Vincente Lucente, who consistently appears as an expert for industry, while he admits to profiting about $1.7M from JNJ.
American Medical Systems (AMS) has just received FDA clearance to market a new incontinence sling called RetroArc, used to treat incontinence.
The Food and Drug Administration has an unreliable way of tracking implanted medical devices. The agency knows it has a problem so it may follow the lead of consumer products.
Continuation from Part I, According to hernia mesh removal surgeon, Dr. Kevin Petersen, a certain number of patients will have an adverse reaction to hernia mesh.
This is an important move by mesh maker J&J - There is now more detailed information about the move by Johnson & Johnson (J&J) to stop the sale of four vaginal mesh implants.
May 22, 2012 ~ The U.S. Food and Drug Administration (FDA) has as its mission the protection of the American people from dangerous consumer products ...
ProPublica, an independent journalism organization, reports on four medical devices that are among the thousands pushed into the market annually with very little scrutiny.
Synthetic surgical mesh has been on the hot seat of late after a 2011 FDA warning said mesh complications are "not rare," a reversal from an earlier FDA position.
Thanks to Courtroom View Network for access to live streaming video of the Perry v. Ethicon trial. Mesh News Desk is prevented from showing any plaint...
When women were injured by the birth control device Essure, they became the driving force behind the removal of the controversial device from the market.
If you have worked with others to help with mesh-induced injuries, this workshop may be the next step in your journey. An Introductory Patient Traini...
2014 should be a very busy year for transvaginal and incontinence mesh lawsuits, if Judge Joseph Goodwin's schedule is any indication.
